Tier 2 — strong
Effects of Ingesting Fucoidan Derived from Cladosiphon okamuranus Tokida on Human NK Cells: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Pilot Study
Marine Drugs
2021
19(6):340
Bibliography
- PubMed
- PMID 34203925
- PubMed Central
- PMC8232719
- Funding
- The research and article-processing charge were funded by South Product.
- Competing interests
- Makoto Tomori and Masahiko Iha received compensation from South Product; the Okinawa mozuku fucoidan test material was supplied by South Product.
Study snapshot
| Design | Randomized double-blind parallel-group placebo-controlled pilot trial |
|---|---|
| Model | Healthy middle-aged adults |
| Sample | 40 participants (20 fucoidan, 20 placebo) |
| Intervention | Cladosiphon okamuranus fucoidan 3.0 g/day in beverage versus placebo |
| Duration | 12 weeks |
| Endpoints | Natural killer cell activity; Blood counts; Biochemistry; Immunological measures; Adverse events |
What the study showed, in plain terms
Key findings
What this study can and cannot tell us
Citation network
Articles citing this research paper
Biohack Blueprint analyses that reference this study in their evidence base.
- Fucoidan Safety: Human Trials, Bleeding Risk & Drug InteractionsFucoidan safety explained from human studies: side effects, anticoagulant concerns, absorption, medication interactions, pregnancy and dose limitations.Read analysis
- SIRT6 Activator Side Effects: Fucoidan, Forvisirvat & Long-Term RisksSIRT6 activator side effects and safety: fucoidan tolerance, bleeding concerns, pregnancy, medications, long-term uncertainty and synthetic activator trial data.Read analysis
- SIRT6 Activator Dosage: Manufacturer Guidance vs Human Trial DosesSIRT6 activator dosage explained: DoNotAge’s 800–2,400 mg guidance, the 2.4 g human trial dose, timing, capsules and what research can actually support.Read analysis
- Fucoidan SIRT6 Activator: The Evidence, In Mice and HumansFucoidan is the leading natural SIRT6 activator candidate. Mouse and mechanistic evidence has now progressed into human testing, including NUS PROMETHEUS and...Read analysis
Editorial review
Reviewed by the Biohack Blueprint research team
Last verified
